Intracranial Hypertension and Dysautonomia: The Overlooked Connection

Idiopathic intracranial hypertension (IIH) — also called pseudotumor cerebri — is a condition of elevated cerebrospinal fluid (CSF) pressure without an identifiable structural cause. It produces a characteristic syndrome of daily headache, visual disturbances, pulsatile tinnitus, and papilledema (optic disc swelling). What is less well-known is that IIH has significant overlap with dysautonomia, POTS, and connective tissue disorders — and that the two conditions can mask each other, leading to years of misdiagnosis.

What Is Intracranial Hypertension?

Normal CSF pressure is 10–20 cm H₂O (approximately 7–15 mmHg). IIH is defined by CSF pressure > 25 cm H₂O on lumbar puncture, with normal CSF composition and no structural cause on neuroimaging. The mechanism is incompletely understood but involves impaired CSF reabsorption at the arachnoid granulations, possibly related to venous sinus stenosis, obesity-related hormonal changes, or — increasingly recognized — connective tissue abnormalities.

IIH predominantly affects women of reproductive age with obesity, but a significant minority of patients are not obese, and this non-obese IIH population has a much higher rate of connective tissue disorders, including hEDS and Marfan syndrome.

The POTS-IIH Overlap

The co-occurrence of POTS and IIH is not coincidental. Several mechanisms link them:

Venous pooling and intracranial pressure. In POTS, venous blood pools in the lower extremities on standing, reducing venous return to the heart and brain. This venous pooling also affects intracranial venous drainage. Impaired cerebral venous outflow raises intracranial pressure — a mechanism that has been demonstrated on MRI venography in POTS patients. Some researchers believe that a subset of POTS patients have subclinical intracranial hypertension that contributes to their headache burden.

Connective tissue vulnerability. Hypermobile EDS and HSD are associated with both POTS (through vascular laxity and autonomic dysfunction) and IIH (through impaired arachnoid granulation function and venous sinus abnormalities). Patients with hEDS have a disproportionately high rate of IIH compared to the general population.

Hormonal factors. Both POTS and IIH worsen with hormonal shifts — particularly high estrogen states. Oral contraceptives containing estrogen are a known IIH trigger and can also worsen POTS. This shared hormonal sensitivity explains why both conditions tend to flare simultaneously in many patients.

Vitamin A metabolism. Elevated retinol (vitamin A) levels are associated with IIH, possibly through effects on CSF production. Some MCAS patients take high-dose vitamin A supplements or have impaired retinol metabolism — a potential IIH risk factor worth discussing with a physician.

Symptoms That Suggest IIH in a POTS Patient

The classic IIH presentation — daily positional headache (worse lying down), pulsatile tinnitus (a whooshing sound in the ears), visual obscurations (brief blackouts of vision), and double vision — is distinctive. However, in POTS patients, these symptoms are often attributed to the POTS itself:

• Headache is nearly universal in POTS and is usually attributed to orthostatic cerebral hypoperfusion
• Pulsatile tinnitus occurs in POTS due to increased sympathetic tone
• Visual disturbances are common in POTS due to orthostatic hypoperfusion

The key distinguishing feature is that IIH headache is typically worse lying down (because CSF pressure increases in the supine position), whereas POTS headache is typically worse standing (due to reduced cerebral perfusion). If a POTS patient's headache is worse lying down or does not improve with recumbency, IIH should be considered.

Papilledema — swelling of the optic disc visible on fundoscopic examination — is pathognomonic for IIH and should be checked in any POTS patient with persistent headache. However, papilledema is absent in approximately 5% of IIH cases (so-called "IIH without papilledema"), and these patients are particularly likely to be misdiagnosed.

Diagnosis

IIH is diagnosed by lumbar puncture with opening pressure measurement, performed with the patient in the lateral decubitus position. Neuroimaging (MRI brain with and without contrast, MR venography) should be performed first to exclude structural causes. MRI findings suggestive of IIH include empty sella turcica, flattening of the posterior globe, distension of the optic nerve sheath, and transverse venous sinus stenosis.

For POTS patients considering lumbar puncture, it is important to ensure adequate volume loading beforehand, as hypovolemia can affect CSF pressure readings.

Treatment

Weight loss is the most effective treatment for obese IIH patients, with sustained remission in many cases. For non-obese patients, weight loss is less relevant.

Acetazolamide (Diamox) is the first-line pharmacological treatment. It reduces CSF production by inhibiting carbonic anhydrase. Doses range from 500 mg to 4 g/day. Side effects include paresthesias, fatigue, kidney stones, and metabolic acidosis — the last of which is particularly relevant for POTS patients who may already have electrolyte imbalances. Acetazolamide also increases urinary sodium and potassium excretion, which can worsen hypovolemia in POTS patients. Careful electrolyte monitoring and increased salt/fluid intake are essential.

Topiramate has modest evidence for IIH and is also a migraine preventive — a useful overlap. It causes less metabolic acidosis than acetazolamide but shares the cognitive side effects ("dopamax").

Venous sinus stenting is increasingly used for IIH patients with significant transverse sinus stenosis, with good results in appropriately selected patients. This is particularly relevant for hEDS patients, who have a high rate of venous sinus abnormalities.

Optic nerve sheath fenestration and CSF shunting are reserved for patients with progressive visual loss despite medical therapy.

Practical Takeaway

Any POTS patient with daily headache that is worse lying down, pulsatile tinnitus, or visual symptoms should be evaluated for IIH. A fundoscopic exam (to check for papilledema) is a simple, non-invasive first step that any physician can perform. If IIH is suspected, referral to a neuro-ophthalmologist or neurologist experienced in CSF disorders is appropriate.

The ChatDys AI can help you document your headache patterns — particularly the positional relationship — and generate a structured summary for your neurologist.